Latest News

Follow the most recent updates from Xsphera Biosciences

April 8, 2024

AACR 2024: Xsphera shares Poster Session on Evaluation of NXI-101 in non-small cell lung cancer (NSCLC)

April 8, 2024

AACR 2024: Xsphera shares Poster Session on Evaluating the Effects of NMC-521 mAb on Fresh Mouse and Patient Derived Organotypic Tumor Spheroids

November 1, 2023

Xsphera Presents at SITC 2023: Understanding Cetuximab Response in Colorectal Cancer

© 2023 Xsphera Biosciences

6 Tide Street

Boston, MA, 02210 — ALL RIGHTS RESERVED